The July 2026 PCAC review will determine whether either peptide is added to the permanent 503A Bulks List
This time, it's not just about a historic disruption to the energy markets, which my colleague Martijn Rats and I discussed on this program last week
Key findings across Phase II and III trials: Women receiving PT-141 showed statistically significant increases in satisfying sexual events per month compared to placebo Reduction in sexual distress scores was observed across multiple validated instruments Effects were noted within the first treatment cycle and maintained across the 12-week study period Response was not limited to any one demographic subgroup efficacy was consistent across age ranges within the premenopausal population Research Context for Male Sexual Dysfunction While PT-141s FDA approval is specifically for HSDD in women, substantial preclinical and Phase II research has examined its effects in men particularly in cases where psychological or neurological factors contribute to sexual dysfunction that vascular agents alone cannot address
It works by stimulating your dermal papilla cells the tiny command centers at the base of each hair follicle that tell your hair when to grow, how thick to grow, and when to stop [1]
Bioma new york City, NY, June 23, 2025 (GLOBE NEWSWIRE) -- Bioma Probiotics In a bold move to reshape the way people think about gut health and overall wellness, Bioma , a leading-edge nutraceutical company, has officially launched its flagship product: Bioma Probiotics a scientifically formulated supplement that targets digestive health, immune support, and mental clarity through microbiome balance
We supply this product for laboratory and research use only
